Cagrilintide has a half-life of about 78 days (roughly 159195 hours measured in a Phase 1b study), and tirzepatide about 5 days (approximately 120 hours)
When analyzed in the laboratory setting, BPC-I57 can be used to explore potential synergistic influences on cellular behavior, angiogenesis, and inflammatory pathways
They have different uses and are not interchangeable
BPC-157 itself has a very short half-life in the body (as low as 30 minutes)which, at first blush, would make it look like a dopers dream
However, because Nrf2 activation primarily affects the lens epithelium and cortex, alternative strategies are required to replenish glutathione in the lens nucleus
It supports the bodys natural detox pathways, particularly Phase II liver detoxification, which neutralizes and eliminates harmful toxins